Fulcrum Therapeutics, Inc. (FULC)
Pharmaceutical Preparations
Latest Price
$3.58
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
4.37
P/B Ratio
0.82
Institutional Ownership
100.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 6.56M | $50.0M | 9.85% | -- | 2026-03-31 |
| RA CAPITAL MANAGEMENT, L.P. | 6.05M | $46.0M | 9.09% | -- | 2026-03-31 |
| BlackRock, Inc. | 5.39M | $41.0M | 8.09% | +1.13M | 2026-03-31 |
| TCG Crossover Management, LLC | 5.25M | $40.0M | 7.88% | -- | 2026-03-31 |
| BRAIDWELL LP | 3.13M | $24.0M | 4.71% | +73.7K | 2026-03-31 |
| Nantahala Capital Management, LLC | 3.05M | $23.0M | 4.58% | -1.24M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.69M | $20.0M | 4.04% | -- | 2026-03-31 |
| Siren, L.L.C. | 2.35M | $18.0M | 3.53% | +400.0K | 2026-03-31 |
| First Turn Management, LLC | 2.26M | $17.0M | 3.39% | +363.4K | 2026-03-31 |
| Aberdeen Group plc | 2.21M | $16.0M | 3.32% | +957.9K | 2026-03-31 |